Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
Br Dent J ; 235(5): 319-322, 2023 09.
Article in English | MEDLINE | ID: mdl-37684458

ABSTRACT

Children and young people can present with a wide variety of symptomatic orofacial pathologies, which can often cause concern. As one presentation may masquerade in multiple pathologies, we start this chapter with a reminder of the surgical sieve used to form a differential diagnosis. An accurate history and examination are essential following which, multiple special investigations may be required. The role of the primary care clinician is recognising soft and hard tissue pathology, considering a differential diagnosis, arranging special investigations, and either initiating care for more straightforward conditions or referring for specialist input. This chapter covers common soft and hard tissue pathology, but is not an exhaustive list.This chapter aims to provide the reader with a practical guide to aid the diagnosis of orofacial pathology in the paediatric age group.


Subject(s)
Diagnosis, Differential , Face , Mouth Diseases , Mouth , Adolescent , Child , Humans , Mouth/pathology , Mouth Diseases/diagnosis , Face/pathology
2.
Br Dent J ; 235(4): 255-261, 2023 08.
Article in English | MEDLINE | ID: mdl-37620475

ABSTRACT

Children and young people can present with a wide variety of symptomatic orofacial pathologies, which can often cause concern. As one presentation may masquerade in multiple pathologies, we start this chapter with a reminder of the surgical sieve used to form a differential diagnosis. An accurate history and examination are essential following which, multiple special investigations may be required. The role of the primary care clinician is recognising soft and hard tissue pathology, considering a differential diagnosis, arranging special investigations, and either initiating care for more straightforward conditions or referring for specialist input. This chapter covers common soft and hard tissue pathology, but is not an exhaustive list.This chapter aims to provide the reader with a practical guide to aid the diagnosis of orofacial pathology in the paediatric age group.


Subject(s)
Diagnosis, Differential , Mouth , Adolescent , Child , Humans , Mouth/pathology
3.
J Oral Pathol Med ; 51(1): 86-97, 2022 Jan.
Article in English | MEDLINE | ID: mdl-34907617

ABSTRACT

BACKGROUND: Oral lichen planus (OLP) is a chronic inflammatory disorder of the oral mucosa. Currently there is no approved treatment for OLP. We report on the efficacy and safety of a novel mucoadhesive clobetasol patch (Rivelin® -CLO) for the treatment of OLP. METHODS: Patients with confirmed OLP and measurable symptomatic ulcer(s) participated in a randomized, double-blind, placebo-controlled, multicenter clinical trial testing a novel mucoadhesive clobetasol patch (Rivelin® -CLO) in OLP across Europe, Canada, and the United States. Patients were randomized to placebo (nonmedicated), 1, 5, 20 µg Clobetasol/patch, twice daily, for 4 weeks. The primary endpoint was change in total ulcer area compared to baseline. Secondary endpoints included improvement from baseline in pain, disease activity, and quality of life. RESULTS: Data were analyzed and expressed as mean [SD]. One hundred thirty-eight patients were included in the study; 99 females and 39 males, mean age was 61.1 [11.6] years. Statistical analyses revealed that treatment with 20-µg Rivelin® -CLO patches demonstrated significant improvement with ulcer area (p = 0.047), symptom severity (p = 0.001), disease activity (p = 0.022), pain (p = 0.012), and quality of life (p = 0.003) as compared with placebo. Improvement in OLP symptoms from beginning to the end of the study was reported as very much better (best rating) in the 20-µg group (25/32) patients compared to the placebo group (11/30), (p = 0.012). Adverse events were mild/moderate. Candidiasis incidence was low (2%). CONCLUSIONS: Rivelin® -CLO patches were superior to placebo demonstrating statistically significant, clinically relevant efficacy in objective and subjective improvement and, with a favorable safety profile.


Subject(s)
Clobetasol , Lichen Planus, Oral , Administration, Topical , Clobetasol/adverse effects , Female , Glucocorticoids , Humans , Lichen Planus, Oral/drug therapy , Male , Middle Aged , Quality of Life
4.
Dent Update ; 43(2): 138-40, 143-6, 149, 2016 Mar.
Article in English | MEDLINE | ID: mdl-27188129

ABSTRACT

Trigeminal neuralgia (TN) is also known as 'tic douloureux' (in French, 'painful twitch'). It is a rare chronic facial pain syndrome, characterized by severe, brief, stabbing, 'electric shock-like 'recurrent pain attacks felt in one or more divisions of trigeminal nerve innervation areas. So intense is the elicited pain that TN has a significant effect on a sufferer's quality of life, rendering many patients unable to consider a future with the ongoing threat of recurrent pain. The aim of this article is to discuss the diagnosis and management of this disabling facial pain condition. CPD/Clinical Relevance: As general medical practitioners may struggle differentiating TN from toothache, primary care dentists have an important role in excluding odontogenic cause of pain, diagnosing TN and referring patients to a facial pain clinic for further investigations and multidisciplinary team management.


Subject(s)
Trigeminal Neuralgia/diagnosis , Anticonvulsants/therapeutic use , Decompression, Surgical/methods , Diagnosis, Differential , Excitatory Amino Acid Antagonists/therapeutic use , Facial Pain/diagnosis , GABA Agents/therapeutic use , Humans , Pain Measurement , Quality of Life , Trigeminal Neuralgia/etiology , Trigeminal Neuralgia/therapy
5.
Oral Surg Oral Med Oral Pathol Oral Radiol ; 120(2): 143-51.e7, 2015 Aug.
Article in English | MEDLINE | ID: mdl-25861956

ABSTRACT

OBJECTIVE: To explore international consensus for the validation of clinical competencies for advanced training in Oral Medicine. STUDY DESIGN: An electronic survey of clinical competencies was designed. The survey was sent to and completed by identified international stakeholders during a 10-week period. To be validated, an individual competency had to achieve 90% or greater consensus to keep it in its current format. RESULTS: Stakeholders from 31 countries responded. High consensus agreement was achieved with 93 of 101 (92%) competencies exceeding the benchmark for agreement. Only 8 warranted further attention and were reviewed by a focus group. No additional competencies were suggested. CONCLUSION: This is the first international validated study of clinical competencies for advanced training in Oral Medicine. These validated clinical competencies could provide a model for countries developing an advanced training curriculum for Oral Medicine and also inform review of existing curricula.


Subject(s)
Clinical Competence , Education, Dental/trends , Internationality , Oral Medicine/education , Curriculum , Humans
SELECTION OF CITATIONS
SEARCH DETAIL
...